HEADER OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR 24-SEP-12 4H96 TITLE CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5- TITLE 2 {3-[3-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-5-METHOXYPHENYL]PROP-1-YN-1- TITLE 3 YL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE (UCP1018) COMPND MOL_ID: 1; COMPND 2 MOLECULE: DIHYDROFOLATE REDUCTASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 1.5.1.3; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CANDIDA ALBICANS; SOURCE 3 ORGANISM_TAXID: 5476; SOURCE 4 GENE: DFR1, DHFR; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET41 KEYWDS ANTIFUNGAL AGENTS, CANDIDA ALBICANS, DRUG DESIGN, ENZYME INHIBITORS, KEYWDS 2 FUNGAL PROTEINS, TETRAHYDROFOLATE DEHYDROGENASE, OXIDOREDUCTASE- KEYWDS 3 OXIDOREDUCTASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.L.PAULSEN,A.C.ANDERSON REVDAT 3 20-SEP-23 4H96 1 REMARK REVDAT 2 20-NOV-13 4H96 1 HET HETATM HETNAM REMARK REVDAT 2 2 1 SITE REVDAT 1 27-MAR-13 4H96 0 JRNL AUTH J.L.PAULSEN,K.VISWANATHAN,D.L.WRIGHT,A.C.ANDERSON JRNL TITL STRUCTURAL ANALYSIS OF THE ACTIVE SITES OF DIHYDROFOLATE JRNL TITL 2 REDUCTASE FROM TWO SPECIES OF CANDIDA UNCOVERS JRNL TITL 3 LIGAND-INDUCED CONFORMATIONAL CHANGES SHARED AMONG SPECIES. JRNL REF BIOORG.MED.CHEM.LETT. V. 23 1279 2013 JRNL REFN ISSN 0960-894X JRNL PMID 23375226 JRNL DOI 10.1016/J.BMCL.2013.01.008 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.53 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 17810 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.249 REMARK 3 R VALUE (WORKING SET) : 0.248 REMARK 3 FREE R VALUE : 0.265 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT : 933 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.67 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1204 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.22 REMARK 3 BIN R VALUE (WORKING SET) : 0.2960 REMARK 3 BIN FREE R VALUE SET COUNT : 67 REMARK 3 BIN FREE R VALUE : 0.3150 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3078 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 156 REMARK 3 SOLVENT ATOMS : 9 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 47.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.01000 REMARK 3 B22 (A**2) : -0.02000 REMARK 3 B33 (A**2) : 0.03000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.127 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.065 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.227 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 11.828 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.920 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.899 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3328 ; 0.006 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4536 ; 0.801 ; 2.025 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 380 ; 2.746 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 142 ;33.754 ;24.085 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 586 ;11.504 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 22 ; 5.981 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 502 ; 0.046 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2444 ; 0.002 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1902 ; 0.038 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3124 ; 0.067 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1426 ; 0.028 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1410 ; 0.050 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TWIN DETAILS REMARK 3 NUMBER OF TWIN DOMAINS : 2 REMARK 3 TWIN DOMAIN : 1 REMARK 3 TWIN OPERATOR : H, K, L REMARK 3 TWIN FRACTION : 0.500 REMARK 3 TWIN DOMAIN : 2 REMARK 3 TWIN OPERATOR : K, H, -L REMARK 3 TWIN FRACTION : 0.500 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 4H96 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-OCT-12. REMARK 100 THE DEPOSITION ID IS D_1000075176. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-OCT-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : D*TREK 9.9.8.8L REMARK 200 DATA SCALING SOFTWARE : D*TREK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17831 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 37.530 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 6.610 REMARK 200 R MERGE (I) : 0.11300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.69 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 6.75 REMARK 200 R MERGE FOR SHELL (I) : 0.55500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1AOE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 61.23 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.17 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3350, KMES, GLYCINE, PH 6.5, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 59.33250 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 59.33250 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 59.33250 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 59.33250 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 19 -32.22 -132.29 REMARK 500 ASN A 47 44.02 39.65 REMARK 500 PRO A 63 127.44 -33.57 REMARK 500 ASN A 123 32.20 -97.00 REMARK 500 LEU A 131 63.04 -107.58 REMARK 500 LYS A 150 75.00 -113.19 REMARK 500 ASN B 47 19.38 48.00 REMARK 500 ASP B 71 18.43 59.32 REMARK 500 ASN B 123 43.68 -96.10 REMARK 500 ASP B 176 73.97 53.51 REMARK 500 REMARK 500 REMARK: NULL REMARK 650 REMARK 650 HELIX REMARK 650 DETERMINATION METHOD: AUTHOR DETERMINED REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NDP A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 14Q A 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NDP B 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 14Q B 202 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3QLS RELATED DB: PDB REMARK 900 RELATED ID: 3QLR RELATED DB: PDB REMARK 900 RELATED ID: 3QLW RELATED DB: PDB REMARK 900 RELATED ID: 3QLY RELATED DB: PDB REMARK 900 RELATED ID: 3QLX RELATED DB: PDB REMARK 900 RELATED ID: 3QLZ RELATED DB: PDB REMARK 900 RELATED ID: 4H95 RELATED DB: PDB REMARK 900 RELATED ID: 4H97 RELATED DB: PDB REMARK 900 RELATED ID: 4H98 RELATED DB: PDB DBREF 4H96 A 4 192 UNP Q5A5E0 Q5A5E0_CANAL 4 192 DBREF 4H96 B 4 192 UNP Q5A5E0 Q5A5E0_CANAL 4 192 SEQRES 1 A 189 PRO ASN VAL ALA ILE ILE VAL ALA ALA LEU LYS PRO ALA SEQRES 2 A 189 LEU GLY ILE GLY TYR LYS GLY LYS MET PRO TRP ARG LEU SEQRES 3 A 189 ARG LYS GLU ILE ARG TYR PHE LYS ASP VAL THR THR ARG SEQRES 4 A 189 THR THR LYS PRO ASN THR ARG ASN ALA VAL ILE MET GLY SEQRES 5 A 189 ARG LYS THR TRP GLU SER ILE PRO GLN LYS PHE ARG PRO SEQRES 6 A 189 LEU PRO ASP ARG LEU ASN ILE ILE LEU SER ARG SER TYR SEQRES 7 A 189 GLU ASN GLU ILE ILE ASP ASP ASN ILE ILE HIS ALA SER SEQRES 8 A 189 SER ILE GLU SER SER LEU ASN LEU VAL SER ASP VAL GLU SEQRES 9 A 189 ARG VAL PHE ILE ILE GLY GLY ALA GLU ILE TYR ASN GLU SEQRES 10 A 189 LEU ILE ASN ASN SER LEU VAL SER HIS LEU LEU ILE THR SEQRES 11 A 189 GLU ILE GLU HIS PRO SER PRO GLU SER ILE GLU MET ASP SEQRES 12 A 189 THR PHE LEU LYS PHE PRO LEU GLU SER TRP THR LYS GLN SEQRES 13 A 189 PRO LYS SER GLU LEU GLN LYS PHE VAL GLY ASP THR VAL SEQRES 14 A 189 LEU GLU ASP ASP ILE LYS GLU GLY ASP PHE THR TYR ASN SEQRES 15 A 189 TYR THR LEU TRP THR ARG LYS SEQRES 1 B 189 PRO ASN VAL ALA ILE ILE VAL ALA ALA LEU LYS PRO ALA SEQRES 2 B 189 LEU GLY ILE GLY TYR LYS GLY LYS MET PRO TRP ARG LEU SEQRES 3 B 189 ARG LYS GLU ILE ARG TYR PHE LYS ASP VAL THR THR ARG SEQRES 4 B 189 THR THR LYS PRO ASN THR ARG ASN ALA VAL ILE MET GLY SEQRES 5 B 189 ARG LYS THR TRP GLU SER ILE PRO GLN LYS PHE ARG PRO SEQRES 6 B 189 LEU PRO ASP ARG LEU ASN ILE ILE LEU SER ARG SER TYR SEQRES 7 B 189 GLU ASN GLU ILE ILE ASP ASP ASN ILE ILE HIS ALA SER SEQRES 8 B 189 SER ILE GLU SER SER LEU ASN LEU VAL SER ASP VAL GLU SEQRES 9 B 189 ARG VAL PHE ILE ILE GLY GLY ALA GLU ILE TYR ASN GLU SEQRES 10 B 189 LEU ILE ASN ASN SER LEU VAL SER HIS LEU LEU ILE THR SEQRES 11 B 189 GLU ILE GLU HIS PRO SER PRO GLU SER ILE GLU MET ASP SEQRES 12 B 189 THR PHE LEU LYS PHE PRO LEU GLU SER TRP THR LYS GLN SEQRES 13 B 189 PRO LYS SER GLU LEU GLN LYS PHE VAL GLY ASP THR VAL SEQRES 14 B 189 LEU GLU ASP ASP ILE LYS GLU GLY ASP PHE THR TYR ASN SEQRES 15 B 189 TYR THR LEU TRP THR ARG LYS HET NDP A 201 48 HET 14Q A 202 30 HET NDP B 201 48 HET 14Q B 202 30 HETNAM NDP NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE HETNAM 2 NDP PHOSPHATE HETNAM 14Q 5-{3-[3-(1,3-BENZODIOXOL-5-YL)-5-METHOXYPHENYL]PROP-1- HETNAM 2 14Q YN-1-YL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE FORMUL 3 NDP 2(C21 H30 N7 O17 P3) FORMUL 4 14Q 2(C23 H22 N4 O3) FORMUL 7 HOH *9(H2 O) HELIX 1 1 LEU A 29 THR A 40 1 12 HELIX 2 2 ARG A 56 GLU A 60 1 5 HELIX 3 3 SER A 95 VAL A 103 1 9 HELIX 4 4 GLY A 114 ILE A 122 1 9 HELIX 5 5 PRO A 152 GLU A 154 5 3 HELIX 6 6 PRO A 160 GLY A 169 1 10 HELIX 7 7 LEU B 29 ARG B 42 1 14 HELIX 8 8 ARG B 56 GLU B 60 1 5 HELIX 9 9 GLU B 97 LEU B 102 1 6 HELIX 10 10 GLY B 114 ILE B 122 1 9 HELIX 11 11 PRO B 152 GLU B 154 5 3 HELIX 12 12 PRO B 160 GLY B 169 1 10 SHEET 1 A 9 GLU A 84 ILE A 85 0 SHEET 2 A 9 ILE A 90 ALA A 93 -1 O HIS A 92 N GLU A 84 SHEET 3 A 9 LEU A 73 LEU A 77 1 N ASN A 74 O ILE A 91 SHEET 4 A 9 ARG A 49 GLY A 55 1 N VAL A 52 O LEU A 73 SHEET 5 A 9 VAL A 106 ILE A 111 1 O PHE A 110 N ILE A 53 SHEET 6 A 9 ASN A 5 LEU A 13 1 N ASN A 5 O VAL A 109 SHEET 7 A 9 VAL A 127 GLU A 136 1 O LEU A 131 N ILE A 8 SHEET 8 A 9 LEU A 188 ARG A 191 -1 O TRP A 189 N LEU A 130 SHEET 9 A 9 TRP A 156 GLN A 159 -1 N THR A 157 O THR A 190 SHEET 1 B 9 GLU A 84 ILE A 85 0 SHEET 2 B 9 ILE A 90 ALA A 93 -1 O HIS A 92 N GLU A 84 SHEET 3 B 9 LEU A 73 LEU A 77 1 N ASN A 74 O ILE A 91 SHEET 4 B 9 ARG A 49 GLY A 55 1 N VAL A 52 O LEU A 73 SHEET 5 B 9 VAL A 106 ILE A 111 1 O PHE A 110 N ILE A 53 SHEET 6 B 9 ASN A 5 LEU A 13 1 N ASN A 5 O VAL A 109 SHEET 7 B 9 VAL A 127 GLU A 136 1 O LEU A 131 N ILE A 8 SHEET 8 B 9 PHE A 182 TYR A 186 -1 O THR A 183 N GLU A 136 SHEET 9 B 9 ILE A 177 GLU A 179 -1 N GLU A 179 O PHE A 182 SHEET 1 C 2 GLY A 18 GLY A 20 0 SHEET 2 C 2 THR A 147 PHE A 148 -1 O THR A 147 N GLY A 20 SHEET 1 D 9 GLU B 84 ILE B 85 0 SHEET 2 D 9 ILE B 90 ALA B 93 -1 O HIS B 92 N GLU B 84 SHEET 3 D 9 LEU B 73 LEU B 77 1 N ILE B 76 O ALA B 93 SHEET 4 D 9 ARG B 49 GLY B 55 1 N MET B 54 O LEU B 77 SHEET 5 D 9 VAL B 106 GLY B 113 1 O PHE B 110 N ILE B 53 SHEET 6 D 9 ASN B 5 LEU B 13 1 N ASN B 5 O VAL B 109 SHEET 7 D 9 VAL B 127 GLU B 136 1 O LEU B 131 N ILE B 8 SHEET 8 D 9 PHE B 182 ARG B 191 -1 O THR B 183 N GLU B 136 SHEET 9 D 9 TRP B 156 GLN B 159 -1 N GLN B 159 O LEU B 188 SHEET 1 E 9 GLU B 84 ILE B 85 0 SHEET 2 E 9 ILE B 90 ALA B 93 -1 O HIS B 92 N GLU B 84 SHEET 3 E 9 LEU B 73 LEU B 77 1 N ILE B 76 O ALA B 93 SHEET 4 E 9 ARG B 49 GLY B 55 1 N MET B 54 O LEU B 77 SHEET 5 E 9 VAL B 106 GLY B 113 1 O PHE B 110 N ILE B 53 SHEET 6 E 9 ASN B 5 LEU B 13 1 N ASN B 5 O VAL B 109 SHEET 7 E 9 VAL B 127 GLU B 136 1 O LEU B 131 N ILE B 8 SHEET 8 E 9 PHE B 182 ARG B 191 -1 O THR B 183 N GLU B 136 SHEET 9 E 9 ILE B 177 GLU B 179 -1 N GLU B 179 O PHE B 182 SHEET 1 F 2 GLY B 18 GLY B 20 0 SHEET 2 F 2 THR B 147 PHE B 148 -1 O THR B 147 N GLY B 20 CISPEP 1 LYS A 14 PRO A 15 0 -1.48 CISPEP 2 ARG A 67 PRO A 68 0 0.75 CISPEP 3 GLY A 113 GLY A 114 0 -1.34 CISPEP 4 LYS B 14 PRO B 15 0 -3.28 CISPEP 5 ARG B 67 PRO B 68 0 -0.90 CISPEP 6 GLY B 113 GLY B 114 0 0.23 SITE 1 AC1 23 VAL A 10 ALA A 11 ILE A 19 GLY A 20 SITE 2 AC1 23 GLY A 23 LYS A 24 MET A 25 GLY A 55 SITE 3 AC1 23 ARG A 56 LYS A 57 THR A 58 LEU A 77 SITE 4 AC1 23 SER A 78 ARG A 79 SER A 94 ILE A 112 SITE 5 AC1 23 GLY A 114 ALA A 115 GLU A 116 ILE A 117 SITE 6 AC1 23 TYR A 118 GLU A 120 14Q A 202 SITE 1 AC2 9 ILE A 9 VAL A 10 ALA A 11 GLU A 32 SITE 2 AC2 9 PHE A 36 SER A 61 ILE A 112 TYR A 118 SITE 3 AC2 9 NDP A 201 SITE 1 AC3 25 VAL B 10 ALA B 11 ILE B 19 GLY B 20 SITE 2 AC3 25 GLY B 23 LYS B 24 MET B 25 ARG B 30 SITE 3 AC3 25 GLY B 55 ARG B 56 LYS B 57 THR B 58 SITE 4 AC3 25 LEU B 77 SER B 78 ARG B 79 SER B 80 SITE 5 AC3 25 SER B 94 ILE B 112 GLY B 114 ALA B 115 SITE 6 AC3 25 GLU B 116 ILE B 117 TYR B 118 GLU B 120 SITE 7 AC3 25 14Q B 202 SITE 1 AC4 11 ILE B 9 VAL B 10 ALA B 11 GLU B 32 SITE 2 AC4 11 PHE B 36 PHE B 66 LEU B 69 ILE B 112 SITE 3 AC4 11 TYR B 118 THR B 133 NDP B 201 CRYST1 118.665 118.665 39.331 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008427 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008427 0.000000 0.00000 SCALE3 0.000000 0.000000 0.025425 0.00000